Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIPPS: LMWH Prophylaxis in Thrombophilic Pregnancy
NCT00967382Phase 3Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Jul 2000
- Primary completion
- Mar 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of dalteparin in thrombophilia, sponsored by Ottawa Hospital Research Institute. Started Jul 2000; status: completed.
02
Drugs
dalteparin
03
Conditions
thrombophilia
Beyond the preview
Go deeper on NCT00967382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00967382.